Clinical characteristics of EOC patients according to their Vδ2+ T cell frequency in PBMCs.

Patients with Vδ2+ T cell frequencies in PBMCs of 0.35% or less (≤0.35%) (n = 11) or greater than 0.35% (>0.35%) (n = 49) at the time of blood collection. Tumor histological type (serous-papillary (SP), endometrioid (E), mucinous (M), clear cell (CC)), tumor grade, FIGO stage, Ca125 concentration, leucocyte concentration, PBMC concentration and patient age at time of blood punction are indicated; PBMC samples collected after chemotherapy are noticed; the optimal debulking of tumor after surgery (no residual tumor nodules), the number of patients who received chemotherapy, the type of chemotherapy and the numbers of patients who were refractory to chemotherapy are indicated; data are presented as medians [first quartile – third quartile] for continuous variable and as numbers (with corresponding percentages) for qualitative variables; nd denotes case not determined;¥ continuous variables were compared using the Mann-Whitney test and categorical variables using the Fisher’s exact test; p value